Taiwan FDA registration 20326f39925d2392b76ee2d3cd21e5b4

Beckman Coulter Gram-negative bacteria urine composite test group 86

TW: 貝克曼庫爾特革蘭氏陰性菌尿液複合檢驗組八十六型

Taiwan·Risk Class 2·BECKMAN COULTER, INC.·Registered Mar 23, 2020 – Mar 23, 2030Active

Registration details

Analysis ID: 20326f39925d2392b76ee2d3cd21e5b4
Customs Code: DHA05603329801

Company information

Manufacturer: BECKMAN COULTER, INC.
Manufacturer Country: United States
Authorized Representative: BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.)

Product details

Intended Use: This product targets aerobic and facultative anaerobic gram-negative bacteria, determines their antibiotic susceptibility, and can be identified to the classification level of "species".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.1640 抗菌感受性試驗粉末
Import Information: QMS/QSD;; 輸入

Dates and status

Registration Date: Mar 23, 2020
Expiry Date: Mar 23, 2030

About this record

Access comprehensive regulatory information for Beckman Coulter Gram-negative bacteria urine composite test group 86 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 20326f39925d2392b76ee2d3cd21e5b4 and manufactured by BECKMAN COULTER, INC.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.